Developmentally dynamic changes in DNA methylation in the human pancreas.

Area of Science:

• Developmental biology
• Epigenetics
• Genomics

Background:

• Human pancreas development relies on precise gene expression control.
• Epigenetic mechanisms, such as DNA methylation, are crucial for this process.
• Transcription factor binding also plays a key role in pancreatic development.

Purpose of the Study:

• To investigate genome-wide DNA methylation patterns during human fetal pancreas development.
• To identify developmental differentially methylated positions (dDMPs) and their associated genes.
• To compare prenatal and postnatal DNA methylation changes and explore sex-specific differences.

Main Methods:

• Quantification of genome-wide DNA methylation in human fetal pancreas samples (6-21 post-conception weeks).
• Analysis of DNA methylation in postnatal pancreas tissue for comparison.
• Comparison of pancreas dDMPs with human brain developmental data.

Main Results:

• Over 21% of DNA methylation sites showed developmental changes (dDMPs) in the fetal pancreas.
• Many dDMPs were linked to genes associated with monogenic diabetes.
• Dramatic DNA methylation changes were primarily observed during the prenatal period.
• Sex-specific DNA methylation differences were identified at autosomal sites.
• dDMPs were depleted in regulatory regions with open chromatin and key transcription factor binding.
• Evidence for tissue-specific developmental DNA methylation changes was found when compared to the human brain.

Conclusions:

• The prenatal period is characterized by significant epigenomic plasticity during human pancreas development.
• DNA methylation patterns are dynamically regulated throughout fetal pancreas development.
• These findings highlight the role of epigenetics in pancreas development and monogenic diabetes.